Gregory Berk - Jul 15, 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Pres. of R&D, CMO
Signature
/s/ Gregory Berk, M.D.
Stock symbol
GTBP
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 09:44 PM
Previous filing
Feb 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50K $0.00 50K Jul 15, 2022 Common Stock 50K $2.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.